Table 4.
Predictive Analysis for Bleeding Outcomes in On‐Treatment Cohort
| Variable | C‐Index (95% CI) | P Value for Comparison | |
|---|---|---|---|
| HAS‐BLED | GARFIELD‐AF | ||
| Major bleeding | 0.60 (0.53–0.68) | 0.55 (0.47–0.63) | 0.352 |
| Major/CRNM bleeding | 0.59 (0.53–0.66) | 0.57 (0.50–0.65) | 0.694 |
| Any bleeding | 0.56 (0.54–0.58) | 0.50 (0.48–0.53) | <0.001 |
CI indicates confidence interval; CRNM, clinically relevant nonmajor; GARFIELD‐AF, Global Anticoagulant in the Field–Atrial Fibrillation; HAS‐BLED, Hypertension, Abnormal renal and liver function, Stroke, Bleeding, Labile INRs, Elderly, Drugs or alcohol.